Por favor, use este identificador para citar o enlazar este ítem: https://observatorio.fm.usp.br/handle/OPI/4388
Título: Sevelamer and CKD-associated cardiovascular disease: going further, but far from there
Autor: MOYSES, Rosa M. A.CANZIANI, Maria E. F.
Citación: KIDNEY INTERNATIONAL, v.84, n.3, p.429-431, 2013
Resumen: Cardiovascular disease is a major complication of chronic kidney disease (CKD), and current data support its link to mineral metabolism disturbances. However, there is an intense debate over whether CKD-mineral and bone disorder therapy could change the cardiovascular burden in CKD. The study by Maizel and colleagues shows the benefits of a phosphate binder, sevelamer, for the progression of aortic stiffness and endothelial dysfunction as well as left ventricular dysfunction and hypertrophy in mice with CKD.
Aparece en las colecciones:

Artigos e Materiais de Revistas Científicas - HC/ICHC
Instituto Central - HC/ICHC

Artigos e Materiais de Revistas Científicas - LIM/16
LIM/16 - Laboratório de Fisiopatologia Renal

Artigos e Materiais de Revistas Científicas - ODS/03
ODS/03 - Saúde e bem-estar


Ficheros en este ítem:
Fichero Descripción TamañoFormato 
art_MOYSES_Sevelamer_and_CKD_associated_cardiovascular_disease_going_further_2013.PDF
  Restricted Access
publishedVersion (English)237.96 kBAdobe PDFVisualizar/Abrir Request a copy

Los ítems de DSpace están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.